Takeda Pharmaceutical Balance Sheet (2017-2026) | TAK

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	5.98B	5.52B	6.37B	7.31B	5.00B	5.78B	4.85B	4.03B	2.31B	2.20B	1.95B	3.09B	5.17B	5.76B	3.25B	2.52B	2.42B	4.63B	4.26B	3.79B
Short-term Investments (Quarter)	2.37B	2.15B	2.03B	0.22B	2.20B	2.38B	1.95B	0.15B	2.14B	2.17B	1.82B	0.10B	2.31B	1.75B	2.61B	0.13B	2.33B	2.48B	2.75B	0.27B
Cash & Current Investments (Quarter)	8.35B	7.67B	8.40B	7.53B	7.20B	8.16B	6.80B	4.19B	4.45B	4.37B	3.77B	3.19B	7.48B	7.51B	5.87B	2.66B	4.75B	7.11B	7.01B	4.06B
Receivables - Net (Quarter)	7.56B	7.66B	6.29B	-0.05B	5.89B	5.50B	5.01B	-0.03B	5.79B	5.23B	4.85B	-0.03B	4.85B	4.70B	4.68B	5.05B	4.60B	4.68B	4.79B	6.23B
Receivables - Other (Quarter)				0.68B				0.56B				0.38B				0.38B				0.23B
Receivables (Quarter)	7.56B	7.66B	6.29B	0.63B	5.89B	5.50B	5.01B	0.53B	5.79B	5.23B	4.85B	0.35B	4.85B	4.70B	4.68B	5.43B	4.60B	4.68B	4.79B	6.46B
Raw Materials (Quarter)
Work In Process (Quarter)
Inventory (Quarter)	7.12B	7.12B	7.14B	7.34B	7.17B	6.90B	6.56B	7.46B	7.91B	8.00B	7.91B	8.16B	8.20B	8.09B	8.20B	7.98B	8.57B	8.82B	9.14B	8.91B
Prepaid Assets (Quarter)	1.22B	1.20B	1.22B	1.21B	1.26B	1.13B	1.10B	1.22B	1.31B	1.23B	1.21B	1.14B	1.27B	1.08B	1.18B	1.05B	1.20B	1.13B	1.14B	1.04B
Current Assets (Quarter)	0.18B	0.18B	0.18B		19.71B	0.04B	0.05B	0.12B	0.11B	0.04B	0.13B	0.06B	0.02B	0.40B	0.44B	16.53B	17.37B	0.09B	0.09B	19.71B
Non-Current Assets
Buildings (Quarter)
Construction in Progress (Quarter)
Land & Improvements (Quarter)
Property, Plant & Equipment (Net) (Quarter)	13.27B	13.26B	13.14B	13.62B	13.19B	12.75B	11.72B	12.79B	13.10B	13.12B	12.46B	13.43B	13.40B	12.65B	13.27B	12.90B	13.52B	13.47B	13.54B	13.52B
Long-Term Investments (Quarter)	1.06B	1.05B	0.92B	0.83B	0.75B	0.70B	0.67B	2.11B	0.73B	0.71B	0.70B	2.30B	0.56B	0.10B	0.08B	2.30B	0.07B	0.06B	0.07B	0.06B
Goodwill (Quarter)	37.08B	37.05B	36.67B	37.93B	37.22B	36.16B	33.20B	36.22B	37.81B	36.71B	34.58B	36.51B	36.83B	34.59B	36.32B	34.90B	36.60B	36.86B	37.38B	37.04B
Intangibles (Quarter)	35.23B	34.37B	33.36B	32.86B	32.05B	30.32B	26.66B	32.28B	32.94B	30.48B	27.72B	28.84B	28.05B	25.28B	26.00B	23.80B	23.65B	22.39B	22.84B	21.80B
Goodwill & Intangibles (Quarter)	72.31B	71.42B	70.02B	70.79B	69.27B	66.48B	59.86B	68.50B	70.75B	67.19B	62.30B	65.35B	64.88B	59.87B	62.32B	58.70B	60.25B	59.25B	60.23B	58.85B
Long-Term Deferred Tax (Quarter)	3.14B	3.05B	3.10B	3.12B	2.98B	2.86B	2.54B	2.77B	2.74B	2.33B	2.14B	2.66B	2.45B	2.27B	2.47B	2.43B	2.77B	2.65B	2.78B	3.48B
Other Non-Current Assets (Quarter)	0.87B	0.86B	0.70B	0.71B	0.65B	0.58B	0.47B	0.48B	0.44B	0.41B	0.37B	0.35B	0.68B	0.57B	0.49B	0.46B	0.47B	0.48B	0.51B	0.49B
Non-Current Assets (Quarter)	93.00B	91.78B	89.91B	91.08B	89.05B	85.75B	77.22B	87.39B	89.90B	85.93B	79.79B	84.69B	84.28B	77.22B	81.25B	76.87B	79.42B	78.38B	79.87B	79.20B
Assets (Quarter)	115.62B	114.10B	111.71B	113.39B	108.76B	105.63B	95.59B	105.52B	107.94B	102.98B	96.22B	101.95B	104.25B	97.70B	99.37B	93.39B	96.79B	98.21B	100.12B	98.91B
Liabilities
Current Liabilities
Accounts Payables (Quarter)	2.93B	3.06B	3.09B	4.44B	3.28B	2.81B	2.70B	4.91B	3.22B	2.92B	3.27B	3.69B	3.01B	2.77B	3.03B	3.12B	2.91B	2.98B	3.04B	3.13B
Payables (Quarter)	2.93B	3.06B	3.09B	4.44B	3.28B	2.81B	2.70B	4.91B	3.22B	2.92B	3.27B	3.69B	3.01B	2.77B	3.03B	3.12B	2.91B	2.98B	3.04B	3.13B
Other Accumulated Expenses (Quarter)	4.73B	4.69B	4.74B	5.03B	4.69B	4.68B	4.53B	4.28B	4.08B	3.99B	3.96B	4.18B	3.63B	3.35B	3.72B	3.91B	3.57B	3.43B	3.69B	3.76B
Short term Debt (Quarter)	40.03B	36.49B	37.23B	1.76B	33.41B	30.18B	27.71B	2.57B	31.60B	30.50B	29.05B	2.48B	32.39B	29.68B	30.95B	3.60B	28.58B	29.53B	27.75B	0.90B
Current Taxes (Quarter)	1.84B	1.71B	1.63B	1.73B	1.93B	1.37B	1.34B	1.76B	1.77B	0.90B	0.76B	0.74B	1.04B	0.95B	1.05B	0.88B	1.04B	0.83B	0.96B	0.62B
Total Current Liabilities (Quarter)	15.59B	17.43B	15.92B	18.46B	16.76B	17.32B	15.83B	18.76B	18.26B	16.39B	15.44B	15.61B	15.84B	16.00B	13.80B	16.43B	14.99B	14.52B	16.96B	18.06B
Non-Current Liabilities
Capital Leases (Quarter)
Non-Current Debt (Quarter)				35.64B				4.04B				4.64B				26.00B				27.86B
Pension (Quarter)	1.47B	1.50B	1.49B	1.25B	1.08B	0.99B	0.94B	0.96B	1.00B	0.93B	0.94B	0.97B	0.96B	0.91B	0.94B	0.89B	0.98B	0.98B	0.98B	0.92B
Minority Interest (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B		0.01B	0.01B	0.01B	0.01B	0.01B	0.01B
Liabilities from Discontinued Operations (Quarter)						0.01B	0.01B	0.00B				0.01B	0.01B					0.00B	0.01B	0.01B
Non-Current Deferred Tax Liability (Quarter)	5.02B	4.97B	4.91B	3.89B	3.53B	3.37B	2.75B	2.05B	1.97B	1.58B	0.90B	0.77B	0.36B	0.31B	0.25B	0.23B	0.23B	0.22B	0.20B	0.17B
Operating Leases (Quarter)
Other Non-Current Liabilities (Quarter)	3.75B	3.77B	3.71B	0.45B	3.60B	3.51B	3.35B	0.42B	3.85B	4.55B	3.26B	0.55B	3.63B	3.40B	3.69B	0.54B	3.48B	3.74B	3.72B	0.64B
Total Non-Current Liabilities (Quarter)	52.18B	48.30B	48.89B	46.03B	43.16B	39.70B	36.04B	38.72B	39.18B	37.62B	35.17B	37.26B	38.31B	35.29B	36.77B	31.50B	34.34B	35.28B	33.49B	33.47B
Total Liabilities (Quarter)	67.77B	65.73B	64.81B	64.49B	59.91B	57.02B	51.87B	57.48B	57.43B	54.02B	50.61B	52.87B	54.14B	51.30B	50.57B	47.93B	49.33B	49.81B	50.45B	51.53B
Shareholder's Equity
Total Debt (Quarter)	40.03B	36.49B	37.23B	37.39B	33.41B	30.18B	27.71B	6.61B	31.60B	30.50B	29.05B	7.12B	32.39B	29.68B	30.95B	29.60B	28.58B	29.53B	27.75B	28.76B
Common Equity (Quarter)	48.42B	48.37B	46.91B	48.92B	48.85B	48.61B	43.72B	48.04B	50.51B	48.96B	45.62B	49.08B	50.10B		48.80B	45.46B	47.45B	48.40B	49.67B	47.38B
Liabilities and Shareholders Equity (Quarter)	115.62B	114.10B	111.71B	113.39B	108.76B	105.63B	95.59B	105.52B	107.94B	102.98B	96.22B	101.95B	104.25B	97.70B	99.37B	93.39B	96.79B	98.21B	100.12B	98.91B
Treasury Shares (Quarter)				0.00B				0.00B
Retained Earnings (Quarter)	14.31B	14.09B	12.90B	12.73B	11.29B	11.08B	10.67B	11.65B	10.87B	10.01B	9.45B	9.39B	8.60B		8.49B	7.78B	7.99B	7.80B	7.12B	4.54B

Research Tools

Developers

Takeda Pharmaceutical Balance Sheet (2017-2026) | TAK

Research Tools

Developers

Takeda Pharmaceutical Balance Sheet (2017-2026) | TAK

Create an account

Sign In

Reset Password